SCHEMBL28700013

SCHEMBL28700013

C#CCN(Cc1ccc(C(=O)Nc2ccccc2N)cc1)Cc1ccccc1C

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 19/20 0.54
HDAC2 Q92769 11/20 0.54
HDAC3 O15379 9/20 0.54
NCOR2 Q9Y618 2/20 0.54
HDAC6 Q9UBN7 5/20 0.47
HDAC4 P56524 4/20 0.47
HDAC7 Q8WUI4 4/20 0.47
HDAC10 Q969S8 4/20 0.47
HDAC11 Q96DB2 4/20 0.47
HDAC8 Q9BY41 4/20 0.47
HDAC9 Q9UKV0 4/20 0.47
HDAC5 Q9UQL6 4/20 0.47
NCOR1 O75376 2/20 0.47
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28932098 0.89 HDAC1 (0.58) HDAC1HDAC2HDAC3NCOR2HDAC6
SCHEMBL28699099 0.89 HDAC1 (0.54) HDAC1HDAC2HDAC3NCOR2HDAC6
SCHEMBL28696687 0.89 HDAC1 (0.54) HDAC1HDAC2HDAC3NCOR2HDAC6
SCHEMBL28931921 0.88 HDAC1 (0.64) HDAC1HDAC2HDAC3NCOR2HDAC6
SCHEMBL28688143 0.87 HDAC1 (0.52) HDAC1HDAC2HDAC3NCOR2HDAC6
SCHEMBL28674214 0.85 HDAC1 (0.63) HDAC1HDAC2HDAC3NCOR2MAPK1
SCHEMBL28932092 0.85 HDAC1 (0.59) HDAC1HDAC2HDAC3NCOR2MAPK1
SCHEMBL28677214 0.85 HDAC1 (0.53) HDAC1HDAC2HDAC3NCOR2HDAC6
SCHEMBL28673092 0.84 HDAC1 (0.67) HDAC1HDAC2HDAC3NCOR2HDAC6
SCHEMBL28697606 0.84 HDAC6 (0.52) HDAC1HDAC2HDAC3HDAC6HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113956182-B HDAC/MAO-B dual inhibitor and preparation and application thereof 杭州师范大学 2023-11-17 CN disclosed
CN-113956182-A HDAC/MAO-B dual inhibitor and preparation and application thereof 杭州师范大学 2022-01-21 CN disclosed